Seeking Alpha HealthcareOriginal article
Cooper outlines Q4 2026 EPS of $1.05-$1.09 while completing strategic review and adding $1B to buyback authorization
EarningsPositive
AI Analysis
Summary
Cooper Companies provided Q4 2026 EPS guidance of $1.05-$1.09 while completing a strategic review and increasing share buyback authorization by $1 billion.
Financial Highlights
EPS
$1.05-$1.09
Guidance
Q4 2026 EPS guidance of $1.05-$1.09
Importance:4/10
Sentiment:
0.30
Earnings GuidanceShare BuybackStrategic Review
Related Companies
Read the original article
Published by Seeking Alpha Healthcare on September 10, 2026 2:37 AM
